About Us
Overview Management Board of Directors Contact Us Fact Sheet
Products
Overview LibiGel® Elestrin™ The Pill-Plus™ Bio-T-Gel™ CaP Cancer Vaccines
Partners & Licensees
Overview Opportunities
Therapeutic Areas
Female Sexual Dysfunction Menopause Contraception Male Hypogonadism Aesthetic Medicine Oncology
Investors
Stock Information Corporate Governance SEC Filings Analyst Coverage Request Information
Newsroom
News Releases Events Webcasts Media Kit

Improving health for life

BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology.


LibiGel® is a transdermal testosterone gel in development for the treatment of female sexual dysfunction (FSD).

08/12/2010 – BioSante Pharmaceuticals Reports Second Quarter 2010 Financial Results » 07/13/2010 – BioSante Pharmaceuticals Announces Initiation of LibiGel® Study to Evaluate its Effect on Cognitive Function in Women »

If you are interested in participating in one of our clinical trials for LibiGel®, please click here for more information.
Copyright © BioSante Pharmaceuticals
Contact Us Site Map NASDAQ:BPAX Legal